Connection

Inderjit Singh to Microbodies

This is a "connection" page, showing publications Inderjit Singh has written about Microbodies.
Connection Strength

3.725
  1. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J Lipid Res. 1998 Nov; 39(11):2161-71.
    View in: PubMed
    Score: 0.153
  2. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):2961-6.
    View in: PubMed
    Score: 0.147
  3. Biochemical features of a patient with Zellweger-like syndrome with normal PTS-1 and PTS-2 peroxisomal protein import systems: a new peroxisomal disease. Biochem Mol Med. 1997 Aug; 61(2):198-207.
    View in: PubMed
    Score: 0.141
  4. Biochemistry of peroxisomes in health and disease. Mol Cell Biochem. 1997 Feb; 167(1-2):1-29.
    View in: PubMed
    Score: 0.136
  5. Mammalian peroxisomes: metabolism of oxygen and reactive oxygen species. Ann N Y Acad Sci. 1996 Dec 27; 804:612-27.
    View in: PubMed
    Score: 0.135
  6. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes. Arch Biochem Biophys. 1996 Oct 15; 334(2):369-79.
    View in: PubMed
    Score: 0.133
  7. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata. J Lipid Res. 1996 May; 37(5):1137-43.
    View in: PubMed
    Score: 0.129
  8. Epoxide hydrolase in human and rat peroxisomes: implication for disorders of peroxisomal biogenesis. J Lipid Res. 1996 Jan; 37(1):159-67.
    View in: PubMed
    Score: 0.126
  9. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes. J Lipid Res. 1995 May; 36(5):986-97.
    View in: PubMed
    Score: 0.120
  10. Effect of hypoxia-reoxygenation on peroxisomal functions in cultured human skin fibroblasts from control and Zellweger syndrome patients. Free Radic Res. 1995 Jan; 22(1):39-46.
    View in: PubMed
    Score: 0.118
  11. Impairment of peroxisomal beta-oxidation system by endotoxin treatment. Mol Cell Biochem. 1994 Jun 29; 135(2):187-93.
    View in: PubMed
    Score: 0.113
  12. CuZn superoxide dismutase: intraorganellar distribution in peroxisomes. Ann N Y Acad Sci. 1994 Jun 17; 723:406-8.
    View in: PubMed
    Score: 0.113
  13. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett. 1994 May 16; 344(2-3):211-5.
    View in: PubMed
    Score: 0.113
  14. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes. FEBS Lett. 1993 Oct 25; 333(1-2):154-8.
    View in: PubMed
    Score: 0.108
  15. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta. 1993 Oct 20; 1182(3):291-8.
    View in: PubMed
    Score: 0.108
  16. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes. J Lipid Res. 1993 Oct; 34(10):1755-64.
    View in: PubMed
    Score: 0.108
  17. Purification of peroxisomes and subcellular distribution of enzyme activities for activation and oxidation of very-long-chain fatty acids in rat brain. Biochim Biophys Acta. 1993 Sep 29; 1170(1):44-52.
    View in: PubMed
    Score: 0.108
  18. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz. J Biol Chem. 1993 May 15; 268(14):9972-9.
    View in: PubMed
    Score: 0.105
  19. Identification of phytanoyl-CoA ligase as a distinct acyl-CoA ligase in peroxisomes from cultured human skin fibroblasts. FEBS Lett. 1993 May 10; 322(2):101-4.
    View in: PubMed
    Score: 0.105
  20. Transport of fatty acids into human and rat peroxisomes. Differential transport of palmitic and lignoceric acids and its implication to X-adrenoleukodystrophy. J Biol Chem. 1992 Jul 05; 267(19):13306-13.
    View in: PubMed
    Score: 0.099
  21. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. Arch Biochem Biophys. 1992 May 15; 295(1):90-100.
    View in: PubMed
    Score: 0.098
  22. Peroxisomal enzyme activities in brain and liver of pups of lactating mothers treated with ciprofibrate. Neurosci Lett. 1992 Apr 27; 138(2):283-6.
    View in: PubMed
    Score: 0.098
  23. Demonstration of Cu-Zn superoxide dismutase in rat liver peroxisomes. Biochemical and immunochemical evidence. J Biol Chem. 1992 Apr 05; 267(10):6870-3.
    View in: PubMed
    Score: 0.097
  24. Peroxisomal activation, transport and oxidation of fatty acids: implications to peroxisomal disorders. Prog Clin Biol Res. 1992; 375:211-22.
    View in: PubMed
    Score: 0.095
  25. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes. Hum Hered. 1992; 42(3):172-8.
    View in: PubMed
    Score: 0.095
  26. Rhizomelic chondrodysplasia punctata: biochemical studies of peroxisomes isolated from cultured skin fibroblasts. Arch Biochem Biophys. 1991 Apr; 286(1):277-83.
    View in: PubMed
    Score: 0.091
  27. Postnatal development and isolation of peroxisomes from brain. J Neurochem. 1991 Apr; 56(4):1343-53.
    View in: PubMed
    Score: 0.091
  28. Topographical localization of peroxisomal acyl-CoA ligases: differential localization of palmitoyl-CoA and lignoceroyl-CoA ligases. Biochemistry. 1990 Apr 24; 29(16):3981-6.
    View in: PubMed
    Score: 0.085
  29. Effect of clofibrate on peroxisomal lignoceroyl-CoA ligase activity. Biochem Med Metab Biol. 1990 Feb; 43(1):22-9.
    View in: PubMed
    Score: 0.084
  30. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biophys. 1989 May 01; 270(2):722-8.
    View in: PubMed
    Score: 0.079
  31. Peroxisomal disorders. Biochemical and clinical diagnostic considerations. Am J Dis Child. 1988 Dec; 142(12):1297-301.
    View in: PubMed
    Score: 0.077
  32. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci U S A. 1988 Oct; 85(20):7647-51.
    View in: PubMed
    Score: 0.076
  33. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. Pediatr Res. 1988 Mar; 23(3):338-41.
    View in: PubMed
    Score: 0.073
  34. Abnormality in translational regulation of catalase expression in disorders of peroxisomal biogenesis. J Neurochem. 1996 Dec; 67(6):2373-8.
    View in: PubMed
    Score: 0.034
  35. Ketoconazole and other imidazole derivatives are potent inhibitors of peroxisomal phytanic acid alpha-oxidation. FEBS Lett. 1995 Dec 18; 377(2):213-6.
    View in: PubMed
    Score: 0.031
  36. Peroxisomal participation in the cellular response to the oxidative stress of endotoxin. Mol Cell Biochem. 1993 Sep 08; 126(1):25-35.
    View in: PubMed
    Score: 0.027
  37. Effect of ciprofibrate on the activation and oxidation of very long chain fatty acids. Mol Cell Biochem. 1991 Feb 02; 100(2):159-67.
    View in: PubMed
    Score: 0.022
  38. Cellular oxidation of lignoceric acid is regulated by the subcellular localization of lignoceroyl-CoA ligases. J Lipid Res. 1990 Apr; 31(4):583-95.
    View in: PubMed
    Score: 0.021
  39. Lipid peroxidation and oxidation of lignoceric acid in kidneys from thioridazine treated rats. J Exp Pathol. 1990; 5(4):177-86.
    View in: PubMed
    Score: 0.021
  40. Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis. 1994 Sep; 15(9):1923-30.
    View in: PubMed
    Score: 0.007
  41. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction. Hum Hered. 1989; 39(5):298-301.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.